Early cytokine release in response to live Borrelia burgdorferi sensu lato spirochetes is largely complement independent

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Sandholm, Kerstin ^a   Henningsson, Anna J ^b,c   Sälve, Susanne ^a   Bergström, Sven ^d   Forsberg, Pia ^c   Jonsson, Nina ^a,e   Ernerudh, Jan ^c   Ekdahl, Kristina N ^a,e  

^a LINNAEUS UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR H; CYTOKINE; HIRUDIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; COMPLEMENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BORRELIA AFZELII; BORRELIA BURGDORFERI; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; WESTERN BLOTTING; METABOLISM; PHYSIOLOGY;

BORRELIA BURGDORFERI GROUP;

BORRELIA BURGDORFERI; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HUMANS; PHAGOCYTOSIS;

EID: 84907482271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108013     Document Type: Article

References (70)

1. Stanek G, Wormser GP, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379:461-473.
2. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, et al. (1995) An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333:1319-1327.
3. Cimmino MA (1998) Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe. European Community Concerted Action on Risk Assessment in Lyme Borreliosis. Infection 26:298-300.
4. Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, et al. (1992) Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378-383.
5. Bacon RM, Kugeler KJ, Mead PS (2008) Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ 57:1-9.
6. van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, et al. (1993) Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 17:708-717.
7. Salazar JC, Pope CD, Sellati TJ, Feder HM Jr, Kiely TG, et al. (2003) Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol 171:2660-2670.
8. Breitner-Ruddock S, Wurzner R, Schulze J, Brade V (1997) Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi. Med Microbiol Immunol 185:253-260.
9. Kraiczy P, Hunfeld KP, Breitner-Ruddock S, Wurzner R, Acker G, et al. (2000) Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates. Immunobiology 201:406-419.
10. Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V (2001) Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol 1:393-401.
11. Kurtenbach K, De Michelis S, Etti S, Schafer SM, Sewell HS, et al. (2002) Host association of Borrelia burgdorferi sensu lato-the key role of host complement. Trends Microbiol 10:74-79.
12. van Dam AP, Oei A, Jaspars R, Fijen C, Wilske B, et al. (1997) Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun 65:1228-1236.
13. Alitalo A, Meri T, Ramo L, Jokiranta TS, Heikkila T, et al. (2001) Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactiva-tion. Infect Immun 69:3685-3691.
14. Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, et al. (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276:8427-8435.
15. Pietikainen J, Meri T, Blom AM, Meri S (2010) Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol Immunol 47:1299-1305.
16. Bykowski T, Woodman ME, Cooley AE, Brissette CA, Wallich R, et al. (2008) Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle. Int J Med Microbiol 298 Suppl 1:249-256.
17. Jozsi M, Zipfel PF (2008) Factor H family proteins and human diseases. Trends Immunol 29:380-387.
18. Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel PF (2001) Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur J Immunol 31:1674-1684.
19. McKisic MD, Barthold SW (2000) T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun 68:5190-5197.
20. Meri T, Cutler SJ, Blom AM, Meri S, Jokiranta TS (2006) Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect Immun 74:4157-4163.
21. Shamaei-Tousi A, Burns MJ, Benach JL, Furie MB, Gergel EI, et al. (2000) The relapsing fever spirochaete, Borrelia crocidurae, activates human endothelial cells and promotes the transendothelial migration of neutrophils. Cell Microbiol 2:591-599.
22. Nilsson Ekdahl K, Nilsson B, Pekna M, Nilsson UR (1992) Generation of iC3 at the interface between blood and gas. Scand J Immunol 35:85-91.
23. Mollnes TE, Lea T, Froland SS, Harboe M (1985) Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 22:197-202.
24. Hammer CH, Wirtz GH, Renfer L, Gresham HD, Tack BF (1981) Large scale isolation of functionally active components of the human complement system. J Biol Chem 256:3995-4006.
25. Welinder C, Ekblad L (2011) Coomassie staining as loading control in Western blot analysis. J Proteome Res 10:1416-1419.
26. Alitalo A, Meri T, Chen T, Lankinen H, Cheng ZZ, et al. (2004) Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H. J Immunol 172:6195-6201.
27. Hazenbos WL, van den Berg BM, van't Wout JW, Mooi FR, van Furth R (1994) Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect Immun 62:4818-4824.
28. Katragadda M, Magotti P, Sfyroera G, Lambris JD (2006) Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J Med Chem 49:4616-4622.
29. Nuutila J, Lilius EM (2005) Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytometry A 65:93-102.
30. Klippel N, Cui S, Groebe L, Bilitewski U (2010) Deletion of the Candida albicans histidine kinase gene CHK1 improves recognition by phagocytes through an increased exposure of cell wall beta-1, 3-glucans. Microbiology 156:3432-3444.
31. Nilsson UR, Storm KE, Elwing H, Nilsson B (1993) Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface. Mol Immunol 30:211-219.
32. Schwab J, Hammerschmidt C, Richter D, Skerka C, Matuschka FR, et al. (2013) Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components. PLoS One 8:e53659.
33. Brade V, Kleber I, Acker G (1992) Differences of two Borrelia burgdorferi strains in complement activation and serum resistance. Immunobiology 185:453-465.
34. Kochi SK, Johnson RC, Dalmasso AP (1991) Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. J Immunol 146:3964-3970.
35. Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA (1988) Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 85:1657-1661.
36. Janulczyk R, Iannelli F, Sjoholm AG, Pozzi G, Bjorck L (2000) Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem 275:37257-37263.
37. Ram S, McQuillen DP, Gulati S, Elkins C, Pangburn MK, et al. (1998) Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med 188:671-680.
38. Kuhn S, Skerka C, Zipfel PF (1995) Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J Immunol 155:5663-5670.
39. Whaley K, Ruddy S (1976) Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science 193:1011-1013.
40. Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729-740.
41. Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, et al. (2004) Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279:2421-2429.
42. Suhonen J, Hartiala K, Tuominen-Gustafsson H, Viljanen MK (2000) Borrelia burgdorferi-induced oxidative burst, calcium mobilization, and phagocytosis of human neutrophils are complement dependent. J Infect Dis 181:195-202.
43. Moore MW, Cruz AR, LaVake CJ, Marzo AL, Eggers CH, et al. (2007) Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect Immun 75:2046-2062.
44. Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, et al. (2008) Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes. Infect Immun 76:56-70.
45. Fijen CA, Bredius RG, Kuijper EJ, Out TA, De Haas M, et al. (2000) The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol 120:338-345.
46. Ko YP, Kuipers A, Freitag CM, Jongerius I, Medina E, et al. (2013) Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface. PLoS Pathog 9:e1003816.
47. Peterson PK, Verhoef J, Sabath LD, Quie PG (1976) Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymor-phonuclear leukocytes. Infect Immun 14:496-501.
48. van Burgel ND, Balmus NC, Fikrig E, van Dam AP (2011) Infectivity of Borrelia burgdorferi sensu lato is unaltered in C3-deficient mice. Ticks Tick Borne Dis 2:20-26.
49. Suhonen J, Komi J, Soukka J, Lassila O, Viljanen MK (2003) Interaction between Borrelia burgdorferi and immature human dendritic cells. Scand J Immunol 58:67-75.
50. Dennis VA, Dixit S, O'Brien SM, Alvarez X, Pahar B, et al. (2009) Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway. Infect Immun 77:1238-1245.
51. Henningsson AJ, Tjernberg I, Malmvall BE, Forsberg P, Ernerudh J (2011) Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation 8:36.
52. Nordberg M, Forsberg P, Johansson A, Nyman D, Jansson C, et al. (2011) Cytotoxic mechanisms may play a role in the local immune response in the central nervous system in neuroborreliosis. J Neuroimmunol 232:186-193.
53. Liba Z, Kayserova J, Komarek V (2013) Th1 and Th17 but no Th2-related cytokine spectrum in the cerebrospinal fluid of children with Borrelia-related facial nerve palsy. Fluids Barriers CNS 10:30.
54. Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A, et al. (2008) Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum 58:3609-3617.
55. Ekerfelt C, Ernerudh J, Bunikis J, Vrethem M, Aagesen J, et al. (1997) Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol 79:155-162.
56. Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, et al. (2004) Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis 189:1881-1891.
57. Sjowall J, Carlsson A, Vaarala O, Bergstrom S, Ernerudh J, et al. (2005) Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol 141:89-98.
58. Giambartolomei GH, Dennis VA, Philipp MT (1998) Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect Immun 66:2691-2697.
59. Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM (2006) IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 177:7076-7085.
60. Steere AC, Angelis SM (2006) Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 54:3079-3086.
61. Blander JM, Medzhitov R (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440:808-812.
62. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, et al. (1999) Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 163:2382-2386.
63. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, et al. (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice. Nat Med 8:878-884.
64. Petzke MM, Brooks A, Krupna MA, Mordue D, Schwartz I (2009) Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol 183:5279-5292.
65. Buffen K, Oosting M, Mennens S, Anand PK, Plantinga TS, et al. (2013) Autophagy modulates Borrelia burgdorferi-induced production of interleukin-1beta (IL-1beta). J Biol Chem 288:8658-8666.
66. Underhill DM, Goodridge HS (2012) Information processing during phagocytosis. Nat Rev Immunol 12:492-502.
67. Cervantes JL, Dunham-Ems SM, La Vake CJ, Petzke MM, Sahay B, et al. (2011) Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proc Natl Acad Sci USA 108:3683-3688.
68. Wilske B, Busch U, Eiffert H, Fingerle V, Pfister HW, et al. (1996) Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol 184:195-201.
69. van Burgel ND, Kraiczy P, Schuijt TJ, Zipfel PF, van Dam AP (2010) Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4. BMC Microbiol 10:43.
70. Henningsson AJ, Ernerudh J, Sandholm K, Carlsson SA, Granlund H, et al. (2007) Complement activation in Lyme neuroborreliosis-increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS. J Neuroimmunol 183:200-207.